Enable Injections Announces $30 Million Investment from Sanofi to Accelerate Manufacturing Capabilities

Enable Injections, Inc. (“Enable”) a healthcare innovation company developing and manufacturing the enFuse® On-Body Delivery ...
Nasdaq

Halozyme Announces Positive Clinical Data of its High-Volume Auto-Injector Demonstrating Successful Rapid Subcutaneous Drug Delivery

Study met primary end point and demonstrated successful subcutaneous administration of a 10 mL biologic co-formulated with ENHANZE® in 30 seconds using Halozyme's proprietary high-volume auto-injector ...
ascopubs.org

Temperature- and volume-dependent dissolution of amifostine 500 mg reconstituted for subcutaneous injection in normal saline or sterile water for injection

Arsenic trioxide induces apoptosis in MDS cell line MUTZ-1 cells via caspase-dependent pathways and down regulation of hTERT ...
Drug Delivery Business

Enable Injections picks up $30M investment from Sanofi

Enable Injections announced today that it received a commitment from Sanofi for a $30 million investment to drive growth.
Business Wire

Simplifying Subcutaneous Drug Administration: SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion

MAINZ, Germany, & MAHWAH, N.J.--(BUSINESS WIRE)--SCHOTT Pharma, a pioneer in pharma drug containment solutions and delivery systems, and KORU Medical Systems (NASDAQ: KRMD), a leading medical ...
FierceBiotech

Unilife Develops Proprietary Portfolio of Wearable Subcutaneous Infusion Devices for the Self-Administration of Large Volume Dru

--The world's first and only wearable, disposable automatic delivery system for self-administration of drugs with dose volumes 5mL or larger --Now available to pharmaceutical companies for use in drug ...
WDAF-TV

Update: Halozyme Announces Presentation of Positive Clinical Data of its High-Volume Auto-Injector Demonstrating Successful Rapid Subcutaneous Drug Delivery at 13th Annual PODD ...

Study met primary end point and demonstrated successful subcutaneous administration of a 10 mL biologic co-formulated with ENHANZE ® in 30 seconds using Halozyme's proprietary high-volume ...